Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

SP ? 4.8mm WN, SLActive? 6mm, TiZr, NTP: medical device reports filed with FDA

2,439 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,439
device reports naming the brand
0% of all MAUDE reports · about 353 a year
358
reports, 12 months to August 2026
398 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,439 medical device reports received by FDA name the brand "SP ? 4.8mm WN, SLActive? 6mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from August 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

358 reports arrived in the 12 months to August 2026, down 10% from 398 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are loss of osseointegration (55.7%), failure to osseointegrate (40.1%) and difficult to insert (0.2%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04386Sep 2021: 28Oct 2021: 35Nov 2021: 38Dec 2021: 302022Jan 2022: 29Feb 2022: 12Mar 2022: 29Apr 2022: 33May 2022: 29Jun 2022: 18Jul 2022: 25Aug 2022: 43Sep 2022: 15Oct 2022: 44Nov 2022: 28Dec 2022: 262023Jan 2023: 21Feb 2023: 17Mar 2023: 28Apr 2023: 29May 2023: 31Jun 2023: 42Jul 2023: 37Aug 2023: 32Sep 2023: 23Oct 2023: 41Nov 2023: 37Dec 2023: 272024Jan 2024: 24Feb 2024: 39Mar 2024: 37Apr 2024: 28May 2024: 39Jun 2024: 18Jul 2024: 31Aug 2024: 24Sep 2024: 34Oct 2024: 42Nov 2024: 25Dec 2024: 422025Jan 2025: 30Feb 2025: 34Mar 2025: 41Apr 2025: 16May 2025: 0Jun 2025: 86Jul 2025: 27Aug 2025: 21Sep 2025: 37Oct 2025: 37Nov 2025: 24Dec 2025: 352026Jan 2026: 19Feb 2026: 29Mar 2026: 33Apr 2026: 37May 2026: 34Jun 2026: 17Jul 2026: 26Aug 2026: 30

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01943882019: 19020192020: 22520202021: 33220212022: 33120222023: 36520232024: 38320242025: 38820252026: 2252026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,439
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report91.3%2,226
Voluntary report0%0
User facility report0%0
Distributor report8.7%213
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Loss of osseointegration1,35955.7%22.4%
Failure to osseointegrate97840.1%62.8%
Difficult to insertthe device was hard to insert60.2%0.4%
Fracturea broken bone60.2%1.6%
Difficult to removethe device was hard to remove30.1%0%
Separation failure20.1%0.1%
Unintended movement20.1%0%
Unstable20.1%0%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,02942.2%
Painpain, site not specified56623.2%
Tissue damage28711.8%
Inflammationinflammation1235%
Hemorrhage/blood loss/bleeding1014.1%
Swelling/ edema763.1%
Hyperresponsive to stimuli532.2%
Hypersensitivity/allergic reaction341.4%
Fistula230.9%
Sinus perforation220.9%
Failure of implant170.7%
Increased sensitivity150.6%
Abscessa collection of pus140.6%
Swellingswelling100.4%
Inadequate osseointegration80.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSP ? 4.8mm WN, SLActive? 6mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports2,4393,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer91.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about SP ? 4.8mm WN, SLActive? 6mm, TiZr, NTP reports

How many FDA reports name SP ? 4.8mm WN, SLActive? 6mm, TiZr, NTP?

2,439 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 358 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

loss of osseointegration (55.7%), failure to osseointegrate (40.1%), difficult to insert (0.2%), fracture (0.2%) and difficult to remove (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (91.3%) and distributor reports (8.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that SP ? 4.8mm WN, SLActive? 6mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.